- Trials with a EudraCT protocol (11)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
11 result(s) found for: Joint Contracture.
Displaying page 1 of 1.
EudraCT Number: 2006-006143-31 | Sponsor Protocol Number: AUX-CC-854.01 | Start Date*: 2007-10-19 | |||||||||||
Sponsor Name:Auxilium UK Limited | |||||||||||||
Full Title: A Phase 3, Open Label Study of Safety and Efficacy of AA4500 in the Treatment of Subjects With Dupuytren's Contracture | |||||||||||||
Medical condition: Dupuytren's Contracture | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) FI (Completed) DK (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000673-40 | Sponsor Protocol Number: 1234 | Start Date*: 2015-01-06 |
Sponsor Name:ous | ||
Full Title: Prospective randomized trial between Percutaneous Needle Fasciotomy and Xiapex injection | ||
Medical condition: Dupuytrens contracture of the hand | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000666-17 | Sponsor Protocol Number: RR37_21_01 | Start Date*: 2022-07-30 | |||||||||||
Sponsor Name:Fidia Farmaceutici Spa | |||||||||||||
Full Title: A Phase II double-blind, randomised, placebo-controlled study of efficacy and safety of Vibrio alginolyticus collagenase administered to patients with Dupuytren contracture | |||||||||||||
Medical condition: Dupuytren contracture | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) DE (Completed) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005065-21 | Sponsor Protocol Number: AUX-CC-862 | Start Date*: 2012-03-26 | |||||||||||
Sponsor Name:Auxilium UK Limited | |||||||||||||
Full Title: Retreatment of recurrent contractures in joints effectively treated with AA4500 (collagenase clostridium histolyticum [XIAFLEX®/XIAPEX®]) in an Auxilium-sponsored Phase 3 Study in the United States... | |||||||||||||
Medical condition: Dupuytren's contracture | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004251-76 | Sponsor Protocol Number: 87230 | Start Date*: 2017-05-22 | ||||||||||||||||
Sponsor Name:University Hospitals of Leicester NHS Trust | ||||||||||||||||||
Full Title: A pragmatic multi-centre randomised controlled non-inferiority, cost effectiveness trial comparing injections of collagenase into the cord to surgical correction in the treatment of moderate Dupuyt... | ||||||||||||||||||
Medical condition: Dupuytren's contracture | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001780-40 | Sponsor Protocol Number: 11069 | Start Date*: 2015-05-21 | |||||||||||
Sponsor Name:University of Oxford, Clinical Trials and Research Governance | |||||||||||||
Full Title: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early... | |||||||||||||
Medical condition: Dupuytren's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004091-19 | Sponsor Protocol Number: AUX-CC-867 | Start Date*: 2012-12-28 | |||||||||||
Sponsor Name:Auxilium UK Limited | |||||||||||||
Full Title: A Phase 3b open-label, historically-controlled study to assess the safety and efficacy of two concurrent injections of AA4500 in adult subjects with multiple Dupuytren’s contractures with palpable ... | |||||||||||||
Medical condition: Dupuytren's contracture | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) GB (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000494-67 | Sponsor Protocol Number: 1.2 | Start Date*: 2013-10-22 | |||||||||||
Sponsor Name:Klinik for håndkirurgi, Gentofte hospital | |||||||||||||
Full Title: Needle fasciotomi vs collagenase for treatment of Dupuytrens contracture in 2nd, 3rd, 4th and 5th metacarpophalangeal joint. | |||||||||||||
Medical condition: Dupuytrens contracture | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019888-10 | Sponsor Protocol Number: B1531002 | Start Date*: 2010-11-10 | |||||||||||
Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: PROSPECTIVE OPEN-LABEL INVESTIGATION OF THE NON-SURGICAL TREATMENT WITH COLLAGENASE CLOSTRIDIUM HISTOLYTICUM (XIAPEX®) | |||||||||||||
Medical condition: Dupuytren’s contracture | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) HU (Completed) ES (Completed) SE (Completed) DK (Completed) DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001221-13 | Sponsor Protocol Number: 2639063 | Start Date*: 2013-10-10 | |||||||||||
Sponsor Name:Akershus university hospital | |||||||||||||
Full Title: Dupytren’s disease study A randomized controlled trial comparing clostridium histolyticum with needle aponeurotomy. | |||||||||||||
Medical condition: Dupytren’s disease, primary MCP joint contractures of the third, forth and fifth finger of the hand. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-006271-42 | Sponsor Protocol Number: HZNP-HZN-825-302 | Start Date*: 2023-01-04 | |||||||||||
Sponsor Name:Horizon Therapeutics Ireland DAC | |||||||||||||
Full Title: A Multicenter, Open-label Extension Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis | |||||||||||||
Medical condition: Diffuse Cutaneous Systemic Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Ongoing) IT (Ongoing) DE (Ongoing) AT (Ongoing) ES (Ongoing) PT (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.